Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiong Lin

Showing results (351-360 of 355) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 355 results.
Journal of Advanced Research|February 4, 2022
Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patientsQing Lei, Cai-Zheng Yu, Yang Li, et al.
Allergy|October 11, 2020
Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infectionsQing Lei, Yang Li, Hong-Yan Hou, et al.
Cell Discovery|August 17, 2021
Systematic profiling of SARS-CoV-2-specific IgG responses elicited by an inactivated virus vaccine identifies peptides and proteins for predicting vaccination efficacyMing-Liang Ma, Da-Wei Shi, Yang Li, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2017
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trialSu-Mei Cao, Qi Yang, Ling Guo, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2019
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trialQi Yang, Su-Mei Cao, Ling Guo, et al.
Pageof 36

Showing results (351-360 of 355) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 355 results.
Journal of Advanced Research|February 4, 2022
Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patientsQing Lei, Cai-Zheng Yu, Yang Li, et al.
Allergy|October 11, 2020
Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infectionsQing Lei, Yang Li, Hong-Yan Hou, et al.
Cell Discovery|August 17, 2021
Systematic profiling of SARS-CoV-2-specific IgG responses elicited by an inactivated virus vaccine identifies peptides and proteins for predicting vaccination efficacyMing-Liang Ma, Da-Wei Shi, Yang Li, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2017
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trialSu-Mei Cao, Qi Yang, Ling Guo, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2019
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trialQi Yang, Su-Mei Cao, Ling Guo, et al.
Pageof 36